These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Equivalents in biotechnology patents. Auer HE Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574 [No Abstract] [Full Text] [Related]
3. US acts to lengthen term of patents to help biotechnology. Wadman M Nature; 1999 Aug; 400(6745):604. PubMed ID: 10458149 [No Abstract] [Full Text] [Related]
9. Inter partes reexamination: a potentially useful approach to challenging invalid biotechnology patents. Derzko NM; Behringer JW Nat Biotechnol; 2003 Jul; 21(7):823-5. PubMed ID: 12833101 [No Abstract] [Full Text] [Related]
10. US Supreme Court applies strict limits to patents. Robertson D Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532 [No Abstract] [Full Text] [Related]
11. US Supreme Court decision could compromise biotech patents. Robertson D Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981 [No Abstract] [Full Text] [Related]
12. What Markman should mean to you. Rzucidlo EC; Auth DR Nat Biotechnol; 1996 Jul; 14(7):888-90. PubMed ID: 9631017 [No Abstract] [Full Text] [Related]
14. Genomics companies welcome US PTO initiative on DNA patents. Marshall A Nat Biotechnol; 1997 Feb; 15(2):121-2. PubMed ID: 9035129 [No Abstract] [Full Text] [Related]
15. Patents. U.S. Supreme Court delves into what is and isn't patentable. Marshall E Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926 [No Abstract] [Full Text] [Related]
16. Process patent bill on track. Gershon D Nature; 1993 Jul; 364(6435):274. PubMed ID: 8332176 [No Abstract] [Full Text] [Related]